Related Experiment Video

Updated: Jun 23, 2026

Myocardial Infarction and Functional Outcome Assessment in Pigs
12:03

Myocardial Infarction and Functional Outcome Assessment in Pigs

Published on: April 25, 2014

No-reflow phenomenon and lesion morphology in patients with acute myocardial infarction

Atsushi Tanaka1, Takahiko Kawarabayashi, Yoshiharu Nishibori

  • 1Department of Cardiology, Baba Memorial Hospital, Sakai, Japan. m4497147@msic.med.osaka-cu.ac.jp

Circulation
|May 8, 2002
PubMed

Insights

Identifying specific plaque characteristics before treatment can predict the no-reflow phenomenon in acute myocardial infarction (AMI) patients. Lipid-rich plaques and larger lesion areas are linked to poor microvascular function post-intervention.

Area of Science:

  • Cardiology
  • Interventional Cardiology
  • Vascular Ultrasound

Background:

  • The no-reflow phenomenon negatively impacts outcomes in acute myocardial infarction (AMI) patients.
  • Accurate identification of high-risk lesions is critical in primary percutaneous coronary intervention (PCI).
  • Limited research exists on the correlation between lesion morphology and no-reflow post-AMI intervention.

Purpose of the Study:

  • To investigate the relationship between pre-intervention intravascular ultrasound (IVUS) detected lesion morphology and the occurrence of the no-reflow phenomenon.
  • To identify specific IVUS-derived morphological predictors of no-reflow in AMI patients undergoing primary intervention.

Main Methods:

  • A prospective study involving 100 AMI patients undergoing primary angioplasty or stenting.
  • Pre-intervention IVUS imaging was performed to assess lesion morphology.
  • Post-intervention assessment for angiographic no-reflow (Thrombolysis In Myocardial Infarction flow grade 0-2) was conducted, excluding mechanical obstructions.

Main Results:

  • Angiographic no-reflow occurred in 13% of patients.
  • Univariate analysis identified hypercholesterolemia, plaque fissure/dissection, lipid-rich plaque, and lesion size as correlates of no-reflow.
  • Multivariate analysis revealed lipid-rich plaque (OR 118) and lesion external elastic membrane cross-sectional area (OR 1.55) as independent predictors of no-reflow.

Conclusions:

  • Large vessels with lipid-rich plaques are associated with a high risk of no-reflow after primary PCI for AMI.
  • Plaque composition, particularly lipid content, may contribute to microcirculatory damage during reperfusion therapy for AMI.
Abstract

More Related Videos

Permanent Ligation of the Left Anterior Descending Coronary Artery in Mice: A Model of Post-myocardial Infarction Remodelling and Heart Failure09:37

Permanent Ligation of the Left Anterior Descending Coronary Artery in Mice: A Model of Post-myocardial Infarction Remodelling and Heart Failure

Published on: December 2, 2014

Primary Outcome Assessment in a Pig Model of Acute Myocardial Infarction14:19

Primary Outcome Assessment in a Pig Model of Acute Myocardial Infarction

Published on: October 14, 2016

Related Concept Videos

Myocarditis I: Introduction01:21

Myocarditis I: Introduction

Myocarditis is inflammation of the myocardium, which is the muscular layer of the heart.EtiologyMyocarditis has a diverse etiology, including a wide range of infectious and non-infectious causes:Infectious CausesViral: Common viruses include Coxsackie A and B, adenovirus, parvovirus B19, enteroviruses, and influenza A.Bacterial: Examples include infections caused by Streptococcus, Staphylococcus, and Mycoplasma species.Rickettsial: Infections like Rocky Mountain spotted fever can result in...
Myocarditis II: Clinical Features and Diagnostic Tests01:27

Myocarditis II: Clinical Features and Diagnostic Tests

Myocarditis is an inflammation of the heart muscle. The symptoms vary widely, encompassing asymptomatic presentations to severe, acute manifestations.Clinical PresentationAsymptomatic cases: In some instances, myocarditis may be asymptomatic, with the infection resolving without intervention. These cases often go undetected unless discovered incidentally through diagnostic imaging or tests conducted for other reasons.General Early Symptoms: Early symptoms of myocarditis are non-specific and can...
Acute Coronary Syndrome I: Introduction01:30

Acute Coronary Syndrome I: Introduction

Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations01:19

Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations

The pathophysiology of Acute Coronary Syndrome [ACD] involves several key processes:The main underlying cause of ACD is atherosclerosis, a chronic inflammatory disease characterized by the buildup of lipid-laden plaques within the coronary arteries.As the atherosclerotic plaque grows in the coronary artery, it may become unstable due to the formation of a lipid-rich core and a thin fibrous cap. Inflammatory cells within the plaque, such as macrophages, secrete enzymes that degrade the...
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...